Summary
Updated Aug 31, 2026
Suneel Gupta is Chief Development Officer of Protagonist Therapeutics, Inc (PTGX). 1 SEC Form 4 filing on record, dated 27 November 2024. Most recent open-market trade: sold $873K of PTGX on 27 November 2024. Lifetime open-market sales: $5.64M.
Recent Transactions
7Every recent SEC Form 4 transaction Suneel Gupta has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Suneel Gupta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dinesh V. Ph D. Patel - $42.34M of PTGX open-market activity in the last 12 months
- Asif Ali - $7.32M of PTGX open-market activity in the last 12 months
- Bryan Giraudo - $5.92M of PTGX open-market activity in the last 12 months
- William D. Waddill - $5.84M of PTGX open-market activity in the last 12 months
- Arturo Md Molina - $4.49M of PTGX open-market activity in the last 12 months
- Harold E. Selick - $2.52M of PTGX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Suneel Gupta?
Suneel Gupta is a corporate insider, tracked as Chief Development Officer of Protagonist Therapeutics, Inc (PTGX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Suneel Gupta last file a Form 4?
The only primary Form 4 on record is dated 27 November 2024.
Has Suneel Gupta been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($5.64M) across all tracked filings.
Where can I see all of Suneel Gupta's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Suneel Gupta and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
